Response: Is heart failure a debatable end-point for bisphosphonate treatment in an older osteoporotic population?

E. L. Grove*, B. Abrahamsen, P. Vestergaard

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

Cite this